Basel Medical Group Ltd (NASDAQ:BMGL)’s traded shares stood at 0.4 million during the last session. At the close of trading, the stock’s price was $1.72, to imply a decrease of -1.15% or -$0.02 in intraday trading. The BMGL share’s 52-week high remains $9.40, putting it -446.51% down since that peak but still an impressive 47.09% since price per share fell to its 52-week low of $0.91. The company has a valuation of $32.32M, with an average of 0.59 million shares in intraday trading volume over the past 10 days and average of 5.62 million shares over the past 3 months.

Basel Medical Group Ltd (NASDAQ:BMGL) trade information

After registering a -1.15% downside in the last session, Basel Medical Group Ltd (BMGL) has traded red over the past five days. The 5-day price performance for the stock is -4.44%, and -66.21% over 30 days. Short interest in Basel Medical Group Ltd (NASDAQ:BMGL) saw shorts transact 0.44 million shares and set a 0.03 days time to cover.

BMGL Dividends

Basel Medical Group Ltd has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.